A pilot study of subcutaneous decitabine in  -thalassemia intermedia

The inherited diseases of hemoglobin are an emerging global health burden

(2010) D. J. Weatherall   BLOOD

Splenectomy and thrombosis: the case of thalassemia intermedia

(2010) A. T. TAHER et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS

Decitabine Maintains Hematopoietic Precursor Self-Renewal by Preventing Repression of Stem Cell Genes by a Differentiation-Inducing Stimulus

(2010) Z. Hu et al.   MOLECULAR CANCER THERAPEUTICS

Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study

(2009) A. T. Taher et al.   BLOOD

Integrative Analysis of Epigenetic Modulation in Melanoma Cell Response to Decitabine: Clinical Implications

(2009) Ruth Halaban et al.   PLoS One

Platelet count in essential thrombocythemia: the more the better?

(2008) A. Tefferi   BLOOD

Hemolysis-associated hypercoagulability in sickle cell disease: the plot (and blood) thickens!

(2008) M. T. Gladwin et al.   HAEMATOLOGICA

Elevated levels of circulating procoagulant microparticles in patients with  -thalassemia intermedia

(2008) A. Habib et al.   HAEMATOLOGICA

Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension

(2008) K. I. Ataga et al.   HAEMATOLOGICA

Platelet count and the risk for thrombosis and death in the elderly

(2008) J. G. VAN DER BOM et al.   JOURNAL OF THROMBOSIS AND HAEMOSTASIS